Femoral Versus Psoas Continuous Peripheral Nerve Blocks Following Hip Arthroplasty

September 23, 2010 updated by: University of California, San Diego
The purpose of this research study is to determine if the insertion site of a perineural catheter, or tiny tube placed next to the nerves that go to the hip which you will have surgery, affects the amount of pain relief that is experienced after surgery.

Study Overview

Detailed Description

To determine the association between perineural catheter location and postoperative analgesia, analgesic requirements, ambulatory distance, and flexion following hip arthroplasty.

Primary Hypothesis: Differing the catheter insertion site (femoral vs. psoas compartment) for a perineural local anesthetic infusion is not associated with lower pain scores during the 24-hour period beginning the morning following hip arthroplasty.

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Diego, California, United States, 92103
        • UCSD Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • primary, unilateral hip arthroplasty or hip resurfacing
  • age greater than or equal to 18 years
  • postoperative analgesic plan includes perineural local anesthetic infusion

Exclusion Criteria:

  • morbid obesity (BMI greater than 40)
  • chronic, high-dose opioid use
  • history of opioid abuse
  • pregnancy
  • incarceration
  • amu meirp-muscular deficit of the ipsilateral femoral nerve and/or quadriceps muscle
  • inability to communicate with hospital staff

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 1. Femoral Nerve Block
Patients will be randomized with a computer program to receive a femoral catheter. The catheter will be placed using standard technique. The time of catheter placement will be recorded as well as the pain/discomfort of catheter placement as reported by the patient on a 0-10 scale where 0=no pain/discomfort and 10=worst imaginable pain/discomfort.
Patients, undergoing hip arthroplasty or hip resurfacing will be randomized to one of two groups: femoral nerve block or psoas compartment nerve block. Patients randomized to femoral nerve block will receive this block prior to surgery. Patients randomized to psoas compartment nerve block will receive this block prior to surgery. Both patients will receive Mepivicaine via catheter prior to surgery and following surgery, Ropivicaine via pain pump.
Active Comparator: 2. Psoas Compartment Catheter
Patients will be randomized with a computer program to receive a psoas compartment catheter. The catheter will be placed using standard technique. The time of catheter placement will be recorded as well as the pain/discomfort of catheter placement as reported by the patient on a 0-10 scale where 0=no pain/discomfort and 10=worst imaginable pain/discomfort.
Patients, undergoing hip arthroplasty or hip resurfacing will be randomized to one of two groups: femoral nerve block or psoas compartment nerve block. Patients randomized to femoral nerve block will receive this block prior to surgery. Patients randomized to psoas compartment nerve block will receive this block prior to surgery. Both patients will receive Mepivicaine via catheter prior to surgery and following surgery, Ropivicaine via pain pump.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Patient's mean pain score (NRS) during perineural infusion as measured by the nursing staff at UCSD and entered in the computer system.
Time Frame: 24 hours beginning 7:30am day following surgery
24 hours beginning 7:30am day following surgery

Secondary Outcome Measures

Outcome Measure
Time Frame
Analgesic used, as reported by nursing staff in the UCSD computer system.
Time Frame: 3 days following surgery
3 days following surgery
Patient's ambulation distance as recorded by therapist (occupational or physical) in the UCSD computer system.
Time Frame: 3 days following surgery
3 days following surgery
Hip flexion, in degrees measured with a standard goneometer, as recorded by therapist (occupational or physical) in the UCSD computer system.
Time Frame: 3 days following surgery
3 days following surgery
Infusion duration of pain pump, measured on the pump itself in hours and minutes.
Time Frame: 3 days following surgery
3 days following surgery
Duration of hospital stay, in hours, as reported in the UCSD computer system.
Time Frame: 3 days following surgery
3 days following surgery
Surgical/anesthetic adverse events as reported by hospital staff
Time Frame: day of surgery and 3 days following
day of surgery and 3 days following
Experiences of patient during the infusion and following, as reported to study staff in a phone conversation, one week following surgery.
Time Frame: 1 week following surgery
1 week following surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2009

Primary Completion (Actual)

August 1, 2010

Study Completion (Actual)

August 1, 2010

Study Registration Dates

First Submitted

August 27, 2009

First Submitted That Met QC Criteria

August 27, 2009

First Posted (Estimate)

August 28, 2009

Study Record Updates

Last Update Posted (Estimate)

September 24, 2010

Last Update Submitted That Met QC Criteria

September 23, 2010

Last Verified

September 1, 2010

More Information

Terms related to this study

Other Study ID Numbers

  • Femoral vs. Psoas PNB Cath Hip

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Arthroplasty

Clinical Trials on Femoral Nerve Block vs. Psoas Compartment Nerve Block

3
Subscribe